Latest News about SRPT
Recent news which mentions SRPT
Over $25M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
August 15, 2023
From Benzinga
From Benzinga
Sarepta Therapeutics (SRPT) Q2 2023 Earnings Call Transcript
August 02, 2023
Tickers
SRPT
From Motley Fool
2 Biotech Growth Stocks I'd Buy Right Now
July 27, 2023
From Motley Fool
From InvestorPlace
Sarepta Therapeutics' Stock Is Down 14% in 1 Month, So Why Does Wall Street Expect It to Rise 65%?
June 30, 2023
Tickers
SRPT
From Motley Fool
Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 23, 2023
From Benzinga
From Benzinga
From Benzinga
Sarepta Therapeutics' Therapy Becomes First To Score FDA Nod For Duchenne Muscular Dystrophy Gene Therapy
June 22, 2023
Tickers
SRPT
From Benzinga
RegenXbio's Potential Blockbuster: Analyst is Bullish On Stock Citing Potential Gains From AAV Gene Therapies Resurgence
June 20, 2023
From Benzinga
From InvestorPlace
Tickers
SRPT
From Motley Fool
Tickers
SRPT
From Motley Fool
Why America's Car-Mart Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 24, 2023
From Benzinga
2 Under-the-Radar Biotech Stocks to Buy in 2023
May 24, 2023
From Motley Fool
Why These 3 Nasdaq Stocks Buckled Today
May 16, 2023
From Motley Fool
Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 15, 2023
From Benzinga
From Benzinga
Why Is Sarepta (SRPT) Stock Up 29% Today?
May 15, 2023
From InvestorPlace
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free